Skip to main content
Tracy Batchelor, MD, Neurology, Boston, MA

TracyToddBatchelorMDMPH

Neurology Boston, MA

Neurooncology

Neurologist-In-Chief, Brigham and Women's Hospital Chair, Department of Neurology, Brigham and Women's Hospital Co-Leader, Neuro-Oncology Program, Dana-Farber/Harvard Cancer Center Miriam Sydney Joseph Professor of Neurology, Harvard Medical School

Dr. Batchelor is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Batchelor's full profile

Already have an account?

  • Office

    Brigham and Women's Hospital
    Hale Building, 4th Floor, 60 Fenwood Road
    Boston, MA 02115
    Phone+1 617-732-5355

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1991 - 1994
  • Yale-New Haven Medical Center
    Yale-New Haven Medical CenterInternship, Internal Medicine, 1990 - 1991
  • Emory University School of Medicine
    Emory University School of MedicineClass of 1990

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1995 - 2026
  • FL State Medical License
    FL State Medical License 2015 - 2017
  • NY State Medical License
    NY State Medical License 1994 - 2001
  • NJ State Medical License
    NJ State Medical License 1995 - 1997
  • American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2012-2020
  • Boston Magazine Castle Connolly, 2011-2020
  • America's Top Doctors for Cancer Castle Connolly, 2011-2020
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Phase I and Biomarker Study of Plerixafor and Bevacizumab in Recurrent High-Grade Glioma  
    Elizabeth Gerstner, Rakesh K Jain, Tracy Batchelor, Clinical Cancer Research
  • Primary Central Nervous System Lymphoma  
    Tracy Batchelor, MD, Seminars in Neurology

Press Mentions

  • Vulnerability in Brain Tumors May Open Door to New Treatments
    Vulnerability in Brain Tumors May Open Door to New TreatmentsSeptember 26th, 2022
  • Regulus Therapeutics Inc (NASDAQ: RGLS) Will Start a Trial for miR-155
    Regulus Therapeutics Inc (NASDAQ: RGLS) Will Start a Trial for miR-155April 8th, 2022
  • New Thinking About What's Fueling Glioma Growth Hint It's in the Synapses
    New Thinking About What's Fueling Glioma Growth Hint It's in the SynapsesOctober 17th, 2019
  • Join now to see all

Grant Support

  • Training Program In Nervous System TumorsNational Cancer Institute2008–2011
  • Clinical And Molecular Studies Of Novel Therapeutics In Malignant Brain TumorsNational Cancer Institute2007–2011
  • Azd2171 And Chemoradiation For Newly Diagnosed GlioblastomaNational Cancer Institute2007–2011
  • Annual Primary CNS Lymphoma Collaborative Group MeetingNational Cancer Institute2006–2010
  • Clinical Trial: A Phase 2 Study Of Azd2171 In Recurrent Glioblastoma (Nci ProtocNational Center For Research Resources2008
  • Nabtt-New Approaches To Brain Tumor Therapy (CNSC)National Cancer Institute2004–2008
  • A Phase 2 Study Of Azd2171 In Recurrent Glioblastoma (Nci Protocol #7105)National Center For Research Resources2007
  • A Phase 2 Study Of Azd2171 In Recurrent GlioblastomaNational Cancer Institute2005–2006